ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/11/10 | 2,187 | 2,208 | 2,185 | 2,193 | -16 | -0.7% | 31,200 |
2022/11/09 | 2,220 | 2,228 | 2,197 | 2,209 | -18 | -0.8% | 44,800 |
2022/11/08 | 2,199 | 2,234 | 2,194 | 2,227 | +35 | +1.6% | 65,000 |
2022/11/07 | 2,192 | 2,199 | 2,171 | 2,192 | ±0 | ±0% | 86,200 |
2022/11/04 | 2,214 | 2,214 | 2,165 | 2,192 | -22 | -1% | 135,100 |
2022/11/02 | 2,194 | 2,245 | 2,194 | 2,214 | +50 | +2.3% | 166,000 |
2022/11/01 | 2,220 | 2,220 | 2,157 | 2,164 | -53 | -2.4% | 100,800 |
2022/10/31 | 2,195 | 2,234 | 2,172 | 2,217 | +61 | +2.8% | 191,000 |
2022/10/28 | 2,131 | 2,158 | 2,119 | 2,156 | -19 | -0.9% | 683,700 |
2022/10/27 | 2,178 | 2,191 | 2,156 | 2,175 | -3 | -0.1% | 116,000 |
2022/10/26 | 2,147 | 2,193 | 2,147 | 2,178 | +31 | +1.4% | 92,400 |
2022/10/25 | 2,130 | 2,156 | 2,130 | 2,147 | +18 | +0.8% | 67,800 |
2022/10/24 | 2,147 | 2,158 | 2,128 | 2,129 | +4 | +0.2% | 70,800 |
2022/10/21 | 2,122 | 2,143 | 2,116 | 2,125 | -9 | -0.4% | 45,800 |
2022/10/20 | 2,126 | 2,138 | 2,116 | 2,134 | -23 | -1.1% | 55,400 |
2022/10/19 | 2,141 | 2,159 | 2,123 | 2,157 | +10 | +0.5% | 74,900 |
2022/10/18 | 2,132 | 2,148 | 2,114 | 2,147 | +31 | +1.5% | 61,200 |
2022/10/17 | 2,120 | 2,129 | 2,107 | 2,116 | -16 | -0.8% | 60,700 |
2022/10/14 | 2,133 | 2,151 | 2,109 | 2,132 | +26 | +1.2% | 86,900 |
2022/10/13 | 2,100 | 2,118 | 2,091 | 2,106 | -8 | -0.4% | 61,900 |
2022/10/12 | 2,093 | 2,116 | 2,085 | 2,114 | +21 | +1% | 93,000 |
2022/10/11 | 2,081 | 2,125 | 2,081 | 2,093 | -18 | -0.9% | 75,600 |
2022/10/07 | 2,109 | 2,130 | 2,109 | 2,111 | -24 | -1.1% | 55,300 |
2022/10/06 | 2,124 | 2,153 | 2,119 | 2,135 | +4 | +0.2% | 71,900 |
2022/10/05 | 2,145 | 2,151 | 2,125 | 2,131 | +9 | +0.4% | 67,900 |
2022/10/04 | 2,083 | 2,122 | 2,079 | 2,122 | +53 | +2.6% | 81,900 |
2022/10/03 | 2,063 | 2,073 | 2,046 | 2,069 | -3 | -0.1% | 53,900 |
2022/09/30 | 2,068 | 2,097 | 2,059 | 2,072 | +8 | +0.4% | 106,400 |
2022/09/29 | 2,029 | 2,069 | 2,014 | 2,064 | +37 | +1.8% | 115,000 |
2022/09/28 | 2,005 | 2,035 | 2,002 | 2,027 | +19 | +0.9% | 140,900 |
2022/09/27 | 1,999 | 2,028 | 1,999 | 2,008 | +13 | +0.7% | 108,600 |
2022/09/26 | 1,984 | 2,003 | 1,984 | 1,995 | -8 | -0.4% | 91,300 |
2022/09/22 | 2,006 | 2,012 | 1,990 | 2,003 | -30 | -1.5% | 118,400 |
2022/09/21 | 2,020 | 2,044 | 2,020 | 2,033 | -7 | -0.3% | 54,300 |
2022/09/20 | 2,043 | 2,051 | 2,031 | 2,040 | +7 | +0.3% | 45,800 |
2022/09/16 | 2,027 | 2,052 | 2,027 | 2,033 | -5 | -0.2% | 68,100 |
2022/09/15 | 2,072 | 2,072 | 2,032 | 2,038 | -23 | -1.1% | 54,000 |
2022/09/14 | 2,049 | 2,069 | 2,046 | 2,061 | -31 | -1.5% | 60,400 |
2022/09/13 | 2,095 | 2,095 | 2,082 | 2,092 | -10 | -0.5% | 37,300 |
2022/09/12 | 2,110 | 2,110 | 2,081 | 2,102 | -6 | -0.3% | 49,800 |
2022/09/09 | 2,085 | 2,117 | 2,085 | 2,108 | +24 | +1.2% | 104,200 |
2022/09/08 | 2,061 | 2,093 | 2,054 | 2,084 | +51 | +2.5% | 86,800 |
2022/09/07 | 2,025 | 2,040 | 2,016 | 2,033 | -7 | -0.3% | 61,900 |
2022/09/06 | 2,060 | 2,074 | 2,032 | 2,040 | -15 | -0.7% | 72,100 |
2022/09/05 | 2,069 | 2,070 | 2,044 | 2,055 | -34 | -1.6% | 69,200 |
2022/09/02 | 2,083 | 2,089 | 2,076 | 2,089 | +12 | +0.6% | 71,100 |
2022/09/01 | 2,064 | 2,093 | 2,064 | 2,077 | -6 | -0.3% | 68,700 |
2022/08/31 | 2,080 | 2,095 | 2,077 | 2,083 | -31 | -1.5% | 67,900 |
2022/08/30 | 2,098 | 2,116 | 2,093 | 2,114 | +16 | +0.8% | 41,500 |
2022/08/29 | 2,088 | 2,105 | 2,081 | 2,098 | -35 | -1.6% | 60,500 |
501~
550
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム